CM
MREO

Caption Management’s Mereo BioPharma MREO Stock Holding History

Caption Management’s Portfolio MREO Stock Details MREO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-380,500
Closed -$784K – 1899
2025
Q3 		$784K Sell
380,500
-57,000
-13% -$105K 0.01% 1183
2025
Q2 		$1.19M Buy
437,500
+132,500
+43% +$320K 0.01% 890
2025
Q1 		$686K Buy
+305,000
New +$863K 0.01% 1013

Other funds holding MREO

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
DCM
Defilade Capital Management Emeryville, California $712M AUM
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WANY
Wealthspire Advisors (New York) New York $12.7B AUM 17.31% 1-Year Est. Return

Caption Management's MREO Position: Q1 2026 in Review

Caption Management increased its Mereo BioPharma (MREO) stake by 28% in Q1 2026, buying an estimated $6.04K and bringing the position to 64,064 shares worth $21.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1455.

Caption Management first reported a position in MREO in Q1 2025 and has held it in 5 quarters since. The position peaked at $535K in Q2 2025. 63 funds tracked by Wall St. Rank hold MREO as of Q1 2026.

  • Caption Management held 64,064 shares of Mereo BioPharma worth $21.1K as of Q1 2026.
  • Caption Management bought 14,064 Mereo BioPharma shares in Q1 2026, an estimated $6.04K.
  • Mereo BioPharma made up ﹤0.01% of Caption Management's portfolio in Q1 2026, its #1455 holding.
  • Caption Management first reported a position in Mereo BioPharma in Q1 2025 and has held it in 5 quarters since.
  • Caption Management's Mereo BioPharma position peaked at $535K in Q2 2025.
  • 63 funds tracked by Wall St. Rank held Mereo BioPharma as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.